Indian J Pharm Close
 

Figure 2: (a) Hemophagocytosis (arrow) in a background of Leishman-Donovan bodies (Giemsa; ×200). (b) Hemophagocytosis along with Leishman-Donovan body within histiocytes (arrow); Inset-hemophagocytosis (arrow head) (Giemsa; ×400). (c) Increased marrow plasma cell percentage (Giemsa; ×200). (d) Mott cell

Figure 2: (a) Hemophagocytosis (arrow) in a background of Leishman-Donovan bodies (Giemsa; ×200). (b) Hemophagocytosis along with Leishman-Donovan body within histiocytes (arrow); Inset-hemophagocytosis (arrow head) (Giemsa; ×400). (c) Increased marrow plasma cell percentage (Giemsa; ×200). (d) Mott cell